Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
| Brand name | METOPROLOL TARTRATE |
| Generic name | METOPROLOL TARTRATE |
| Active ingredient(s) | METOPROLOL TARTRATE |
| Distributed by / for | Westminster Pharmaceuticals, LLC, Nashville, TN 37217 |
| NDC | 69367-354-10 |
| Full product label | Metoprolol Tartrate Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2), Noyapara, Bhawal Mirzapur, Rajendrapur, Gazipur, 1700 Bangladesh, Distributed by: Westminster Pharmaceuticals, LLC, Nashville, TN 37217, NDC 69367-354-10 |
| Recalling firm | Westminster Pharmaceuticals LLC |
| Distribution | Nationwide in the USA. |
| Quantity | 16,672 1000-count bottles |
| Recall initiated | 2025-08-06 |
| Report date | 2025-08-20 |
| Recall completed | — |
| Recall number | D-0581-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Nashville TN United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗